Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
41.14%
↑ 128% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-147.31%
Historical baseline
PeriodValue
202541.14%
202415.78%
2023-128.28%
2022-415.85%
202154.95%
2020-527.80%
2019-218.37%
20180.00%